Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.00
(
-0.75%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
103.91
(
-0.48%
)
Bitcoin
76,346.41
(
0.00%
)
News Focus
News Focus
Post# of 257458
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122898
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 233292

Monday, 07/20/2020 11:47:44 AM

Monday, July 20, 2020 11:47:44 AM

Post# of 257458
ASMB—(+10%)—inks deal with BGNE for Greater-China development/commercialization of ASMB’s HBV core inhibitors—$40M up-front cash for ASMB ($500M biobucks):

https://www.globenewswire.com/news-release/2020/07/20/2064219/0/en/Assembly-Biosciences-and-BeiGene-Announce-License-and-Collaboration-Agreement-in-China-for-Assembly-s-Portfolio-of-Three-Clinical-Stage-Core-Inhibitors-for-Chronic-Hepatitis-B-Infe.html

*Includes Taiwan, Hong Kong, Macao.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today